Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- INSM -3.1%
Other news:
- CHRW -11.8% (Agreed to acquire RXO in a $5.8 billion cash-and-stock deal, targeting $300 million in run-rate cost synergies.)
- NIU -3.2% (Reported Q3 sales volume of 537,457 units, up 15% year-over-year, as international sales more than tripled.)
- VELO -2.4% (Appointed Terence P. Wynn interim CFO following James Suva’s departure, which was unrelated to any company disagreement.)
- CVE -1.9% (Agreed to acquire Athabasca Oil for C$5.7 billion, adding 45,000 BOE/d and C$85 million in annual synergies.)
- ACIC -1.2% (COO and CIO Christopher Griffith resigned effective October 1 to pursue another opportunity.)
- NVO -1.1% (FDA extended denecimig’s review due to manufacturing remediation, with no new decision timeline provided.)
- GILD -1.1% (Extends an oncology research program with Nurix by two years, paying a $10 million fee.)